Nourecs Digestive Multi Enzyme Capsule
Natural health product licensed in Canada
- Licence holder
- Nources Inc.
- NPN or DIN-HM
- 80057100
- Status
- Active licence
- Licence date
- 9 January 2015
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-galactosidase Source : Lactase | 20 mg | Not calculated |
| bêta-galactosidase Source : Lactase | 20 FCC ALU | Not calculated |
| bêta-fructofuranosidase Source : Invertase | 30 mg | Not calculated |
| bêta-fructofuranosidase Source : Invertase | 30 FCC INVU | Not calculated |
| Papaïne Source : Papain | 50 mg | Not calculated |
| Papaïne Source : Papain | 100,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 750,000 FCC PU | Not calculated |
| Bromélaïne de tige Source : Bromélaïne de tige | 50 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Hemicellulase | 20 mg | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Hemicellulase | 100 FCC HCU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 160 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Cellulase | 40 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 250 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 50 mg | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 300 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Triacylglycerol lipase | 30 mg | Not calculated |
| Protéase Source : Protéase fongique | 4,500 FCC HUT | Not calculated |
| Protéase Source : Protéase fongique | 180 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 days | minimum: 1 Capsule ; maximum: 2 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Digestive enzymes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057100
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.